News

European Commission (EC) has published a new version of the Questions & Answers document on “Safety Features for Medicinal Products for Human Use (V.19)”.

The European Commission has taken decision to extend the transitional period for a period of three years, which was determined in the context of the action of the medicine verification system regarding the medicine products exported to the United Kingdom* (UK) following its’ withdrew from the European Union.

Lai pārliecinātos, vai pašreizējais gala lietotāja izmantotais IT risinājums ir gatavs sistēmas izmaiņām, LZVO aicina laicīgi sazināties ar savu IT pakalpojumu sniedzēju.

In 2021 the Latvian Medicines Verification System has been operating stably, constantly ensuring the verification of medicines that are available to the Latvian population through legal supply chains, according to the annual report 2021 of the Latvian Medicines Verification Organization.

LZVO 2. martā organizēja semināru saviem partneriem – IT piegādātājiem, lai informētu viņus par sistēmas attīstību un citām aktualitātēm.

The customer satisfaction survey conducted by the Latvian Medicines Verification Organization (LZVO) received a high evaluation for its customer service.